Vascular Biology |
From Bristol Heart Institute, Department of Cardiac, Anesthetic, and Radiological Sciences, University of Bristol, Bristol Royal Infirmary, Bristol, UK.
Correspondence to Dr Sarah Jane George, Bristol Heart Institute, Level 7, Bristol Royal Infirmary, Upper Maudlin Street, Bristol, BS2 8HW, UK. E-mail s.j.george{at}bris.ac.uk
Objective Vascular smooth muscle cell (VSMC) proliferation is an important component of atherosclerosis, restenosis after angioplasty and stent placement, and vein graft failure. Outside-in signaling from the cadherin:ß-catenin complex can increase transcription of the cell-cycle gene cyclin D1; however, its role in VSMC proliferation has only recently been considered.
Methods and Results We examined the involvement of R-cadherin and ß-catenin in VSMC proliferation in balloon-injured carotid arteries in vivo and aortic rings in vitro. The number of medial VSMCs positive for R-cadherin was significantly reduced by 32%±5%, 52%±10%, and 23%±2% at 0.25, 24, and 48 hours after injury in vivo, respectively. These changes in cadherin expression coincided with the detection of nuclear ß-catenin and elevated cyclin D1 expression. Furthermore, loss of R-cadherin expression was associated with medial VSMC proliferation. Inhibition of classical cadherin function with a HAV peptide and R-cadherin neutralizing antibodies significantly increased proliferation by 4.3±1.0-fold and 4.1±0.98-fold, and increased the number of cells with ß-catenin in the nucleus and expressing cyclin D1 in aortic rings.
Conclusions These results suggest that R-cadherin expression and ß-catenin signaling may be associated with increased cyclin D1 expression and VSMC proliferation and may therefore play an important role in vascular disease.
Human VSMCs that overexpress AIF-1 grow more rapidly and express G-CSF. G-CSF is capable of promoting VSMC proliferation, and AIF-1-transduced VSMCs are chemotactic for monocytes. This study indicates that AIF-1 enhances VSMC growth by autocrine production of G-CSF, and AIF-1 expression may influence VSMC-inflammatory cell communication.
Key Words: smooth muscle cadherin proliferation intimal thickening
This article has been cited by other articles:
![]() |
A. Bedel, A. Negre-Salvayre, S. Heeneman, M.-H. Grazide, J.-C. Thiers, R. Salvayre, and F. Maupas-Schwalm E-Cadherin/{beta}-Catenin/T-Cell Factor Pathway Is Involved in Smooth Muscle Cell Proliferation Elicited by Oxidized Low-Density Lipoprotein Circ. Res., September 26, 2008; 103(7): 694 - 701. [Abstract] [Full Text] [PDF] |
||||
![]() |
R. O. Nunes, M. Schmidt, G. Dueck, H. Baarsma, A. J. Halayko, H. A. M. Kerstjens, H. Meurs, and R. Gosens GSK-3/{beta}-catenin signaling axis in airway smooth muscle: role in mitogenic signaling Am J Physiol Lung Cell Mol Physiol, June 1, 2008; 294(6): L1110 - L1118. [Abstract] [Full Text] [PDF] |
||||
![]() |
H. Quasnichka, S. C. Slater, C. A. Beeching, M. Boehm, G. B. Sala-Newby, and S. J. George Regulation of Smooth Muscle Cell Proliferation by {beta}-Catenin/T-Cell Factor Signaling Involves Modulation of Cyclin D1 and p21 Expression Circ. Res., December 8, 2006; 99(12): 1329 - 1337. [Abstract] [Full Text] [PDF] |
||||
![]() |
R. Hou, L. Liu, S. Anees, S. Hiroyasu, and N. E.S. Sibinga The Fat1 cadherin integrates vascular smooth muscle cell growth and migration signals J. Cell Biol., May 8, 2006; 173(3): 417 - 429. [Abstract] [Full Text] [PDF] |
||||
![]() |
C. van Breemen, D. Poburko, and E. B. Okon TRP Proteins: A New Dimension in the Treatment of Occlusive Vascular Disease Circ. Res., March 3, 2006; 98(4): 446 - 447. [Full Text] [PDF] |
||||
![]() |
A. C. Newby Matrix metalloproteinases regulate migration, proliferation, and death of vascular smooth muscle cells by degrading matrix and non-matrix substrates Cardiovasc Res, February 15, 2006; 69(3): 614 - 624. [Abstract] [Full Text] [PDF] |
||||
|
ATVB Home | Subscriptions | Archives | Feedback | Authors | Help | AHA Journals Home | Search Copyright © 2004 American Heart Association, Inc. All rights reserved. Unauthorized use prohibited. |